Clinical Trials
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Clinical Trials | CRO News | Information Technology
ICON Enhances Endpoint Adjudication Services
Will leverage AG Mednet's comprehensive electronic endpoint adjudication system06.11.18
-
Bio News | Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery
GE, XPH Enter FlexFactory Agreement
To scale up, digitize & accelerate manufacturing processes for their cell therapy clinical trials & future commercialization06.07.18
-
Clinical Trials | Drug Development | Industry News | Information Technology
Ready for ASCO
Why ASCO’s annual meeting is one of the most important events in the oncology communityDr. Eric Groves, Vice President of Strategic Drug Development, R&D Solutions, IQVIA 06.01.18
-
Clinical Trials | CRO News | Laboratory Testing
ACM Global Labs Adds New Testing Services for Oncology Trials
Introduces therapeutic service offering to support the specific testing needs of oncology clinical trials06.01.18
-
Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
PPD and NeoGenomics Form Global Strategic Alliance
Expanding global oncology testing for clinical trials06.01.18
-
Clinical Trials | Drug Development
CRO Perspectives: PAREXEL
Sy Pretorius addresses trends, what is and isn’t working well in partnership models, and where the industry can improveOnline Exclusives Kristin Brooks , Contract Pharma 06.01.18
-
Bio News | Clinical Trials | Drug Discovery | Industry News | Trials & Filings
FDA Grants Curis Fast Track Designation
For fimepinostat (formerly CUDC-907) in adult patients with relapsed or refractory diffuse large B-cell lymphoma05.31.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News
Catalent, InterveXion Announce First Enrollment in STAMPOUT
The first trial in methamphetamine users of the first-in-class anti-methamphetamine antibody IXT-m20005.31.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News | Methods Development
NEOMED-LABS, GSK Extend Agreement
NEOMED-LABS will develop immunotools, immunochemical assays, and functional assays and undertake project testing for GSK05.31.18
-
Bio News | Clinical Trials | Drug Discovery | Industry News | Trials & Filings
FDA Signs Off On Janssen Phase 1b/2 Trial
To evaluate a Chimeric Antigen Receptor T cell (CAR-T) therapy in patients with relapsed or refractory Multiple Myeloma05.30.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | Laboratory Testing | R&D
Oncternal, Pharmacyclics Enter Supply Agreement
Pharmacyclics to supply ibrutinib, a small molecule inhibitor of Bruton's tyrosine kinase (BTK), for a Phase 1b/2 trial05.29.18
-
Clinical Trials | CRO News | Drug Development
WCG Clinical Opens Office in Tokyo
Expanded presence in the Asia-Pacific region to support increasingly complex, global clinical trials05.22.18
-
Clinical Trials | CRO News | Drug Development | Information Technology
PPD, Evidera Join NEWDIGS Initiative at MIT
Collaboration aims to develop solutions for industry wide obstacles to biomedical innovation05.22.18
-
Clinical Trials | Drug Development
CRO Strategies: ICON Perspective
ICON's Nuala Murphy discusses outsourcing in today’s market, overcoming challenges, and partnership modelsOnline Exclusives Kristin Brooks, Contract Pharma 05.21.18
-
Bio News | Clinical Trials | Drug Development | Drug Discovery | Industry News | Trials & Filings
Roche Announces HAVEN 3 & HAVEN 4 Study Results
Roche’s Hemlibra reduced treated bleeds by 96 percent compared to no prophylaxis in the phase 3 HAVEN 3 study05.21.18
-
Bio News | Clinical Trials | Drug Development | Drug Discovery | Industry News | R&D | Trials & Filings
Avenue Announces Positive Phase 3 Trial Results
For IV tramadol, for the severe postoperative pain following surgery05.21.18
-
Clinical Trials | Drug Development | Drug Discovery | Industry News | Trials & Filings
Nabriva Announces Positive Trial Results
From its LEAP 2 clinical trial, the second of two global, pivotal Phase 3 clinical trials of lefamulin05.21.18
-
Bio News | Clinical Trials | Drug Development | Drug Discovery | Industry News | Trials & Filings
FDA Grants Harmony Breakthrough Therapy & Fast Track Designations
For its investigational product, pitolisant, for the treatment of narcolepsy05.21.18
-
Clinical Trials | Collaborations & Alliances | Drug Development
Oncolytics, Merck, Northwestern Conduct Phase II Combo Trial
Will further evaluate Keytruda and REOLYSIN in second line pancreatic cancer05.17.18
-
Bio News | Breaking News | Clinical Trials | Drug Development | Drug Discovery | Industry News | Laboratory Testing | Trials & Filings
Lilly's Galcanezumab Meets Phase 3 Endpoint
For patients with episodic cluster headache, demonstrating significant differences in the reduction compared to placebo05.15.18
